Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ROBERT FRIEDMAN

Allopathic & Osteopathic Physicians Physical Medicine & Rehabilitation

NPI
1457337446
CMS profile
338728
Location
BOISE, ID

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$11,712.62

61 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Page 2 of 2; records 51–61 of 61 matching records. This page contains 11 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ROBERT FRIEDMAN

NPI 1457337446 · CMS profile ID 338728

Allopathic & Osteopathic Physicians / Physical Medicine & Rehabilitation

BOISE, ID

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–61 of 61 matching records. This page contains 11 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1457337446?year=2024&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ROBERT FRIEDMAN, NPI 1457337446, CMS profile ID 338728. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–61 of 61 matching records. This page contains 11 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1457337446?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). ROBERT FRIEDMAN, NPI 1457337446, CMS profile ID 338728. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–61 of 61 matching records. This page contains 11 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1457337446?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
ROBERT FRIEDMAN, NPI 1457337446, CMS profile ID 338728, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–61 of 61 matching records. This page contains 11 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1457337446?year=2024&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

61 matching records · $11,712.62 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 61 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–61 of 61.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
GENZYME CORPORATION $30.2302/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139600316 CMS
PIRAMAL CRITICAL CARE $18.4902/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1144460530 CMS
PFIZER INC. $16.4502/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131166041 CMS
HydroCision, Inc. $57.3902/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1154968583 CMS
ABBVIE INC. $5.2801/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103756481 CMS
ABBVIE INC. $7.6701/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103756483 CMS
Ipsen Biopharmaceuticals, Inc $26.0101/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1091953046 CMS
Biogen, Inc. $15.4901/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104828992 CMS
ABBVIE INC. $5.9601/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103756479 CMS
PIRAMAL CRITICAL CARE $9.8701/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1144460368 CMS
ABBVIE INC. $26.0801/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103756477 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $875.77 45
PY2020 $590.73 36
PY2021 $3,370.01 35
PY2022 $629.90 24
PY2023 $514.31 24
PY2024 $11,712.62 61
PY2025 $597.05 30

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2023 Principal investigator $18,161.15 194
PY2022 Principal investigator $23,132.62 3
PY2021 Principal investigator $24,479.93 145

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

194 records in PY2023

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 MDD US Operations, LLC $2.02 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921679
Principal investigator 1 MDD US Operations, LLC $2.70 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921685
Principal investigator 1 MDD US Operations, LLC $5.40 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921691
Principal investigator 1 MDD US Operations, LLC $10.12 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921703
Principal investigator 1 MDD US Operations, LLC $20.25 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921709
Principal investigator 1 MDD US Operations, LLC $3.38 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921715
Principal investigator 1 MDD US Operations, LLC $2.70 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921721
Principal investigator 1 MDD US Operations, LLC $20.25 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921727
Principal investigator 1 MDD US Operations, LLC $5.40 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921733
Principal investigator 1 MDD US Operations, LLC $5.40 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921739
Principal investigator 1 MDD US Operations, LLC $2.02 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921747
Principal investigator 1 MDD US Operations, LLC $2.02 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921753
Principal investigator 1 MDD US Operations, LLC $6.75 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921759
Principal investigator 1 MDD US Operations, LLC $67.50 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921771
Principal investigator 1 MDD US Operations, LLC $17.28 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921777
Principal investigator 1 MDD US Operations, LLC $40.50 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921785
Principal investigator 1 MDD US Operations, LLC $2.70 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921791
Principal investigator 1 MDD US Operations, LLC $20.25 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921797
Principal investigator 1 MDD US Operations, LLC $10.12 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921803
Principal investigator 1 MDD US Operations, LLC $3.38 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921809
Principal investigator 1 MDD US Operations, LLC $6.08 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921815
Principal investigator 1 MDD US Operations, LLC $23.62 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921821
Principal investigator 1 MDD US Operations, LLC $20.25 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921827
Principal investigator 1 MDD US Operations, LLC $5.40 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921839
Principal investigator 1 MDD US Operations, LLC $2.70 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921845
Principal investigator 1 MDD US Operations, LLC $2.02 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921851
Principal investigator 1 MDD US Operations, LLC $5.40 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921857
Principal investigator 1 MDD US Operations, LLC $5.40 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921863
Principal investigator 1 MDD US Operations, LLC $3.38 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921869
Principal investigator 1 MDD US Operations, LLC $10.12 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921875
Principal investigator 1 MDD US Operations, LLC $5.40 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921881
Principal investigator 1 MDD US Operations, LLC $2.70 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921889
Principal investigator 1 MDD US Operations, LLC $5.40 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921893
Principal investigator 1 MDD US Operations, LLC $6.08 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921905
Principal investigator 1 MDD US Operations, LLC $10.12 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921913
Principal investigator 1 MDD US Operations, LLC $5.40 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921917
Principal investigator 1 MDD US Operations, LLC $2.70 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921925
Principal investigator 1 MDD US Operations, LLC $16.88 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921931
Principal investigator 1 MDD US Operations, LLC $67.50 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921935
Principal investigator 1 MDD US Operations, LLC $6.08 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921941
Principal investigator 1 MDD US Operations, LLC $5.40 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921947
Principal investigator 1 MDD US Operations, LLC $13.50 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921953
Principal investigator 1 MDD US Operations, LLC $2.70 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921961
Principal investigator 1 MDD US Operations, LLC $5.40 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921973
Principal investigator 1 MDD US Operations, LLC $23.62 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921979
Principal investigator 1 MDD US Operations, LLC $5.40 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921985
Principal investigator 1 MDD US Operations, LLC $5.40 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921991
Principal investigator 1 MDD US Operations, LLC $20.25 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921997
Principal investigator 1 MDD US Operations, LLC $2.70 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052922009
Principal investigator 1 MDD US Operations, LLC $5.40 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052922015
Principal investigator 1 MDD US Operations, LLC $6.75 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052922021
Principal investigator 1 MDD US Operations, LLC $40.50 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052922027
Principal investigator 1 MDD US Operations, LLC $3.38 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052922033
Principal investigator 1 MDD US Operations, LLC $5.40 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052922047
Principal investigator 1 MDD US Operations, LLC $5.40 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052922053
Principal investigator 1 MDD US Operations, LLC $5.40 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052922059
Principal investigator 1 MDD US Operations, LLC $5.40 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052922065
Principal investigator 1 MDD US Operations, LLC $5.40 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052922071
Principal investigator 1 MDD US Operations, LLC $23.62 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052922077
Principal investigator 1 MDD US Operations, LLC $5.40 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052922083
Principal investigator 1 MDD US Operations, LLC $20.25 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052922089
Principal investigator 1 MDD US Operations, LLC $20.25 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052922094
Principal investigator 1 MDD US Operations, LLC $20.25 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052922099
Principal investigator 1 MDD US Operations, LLC $40.50 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052922111
Principal investigator 1 MDD US Operations, LLC $2.70 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052922117
Principal investigator 1 MDD US Operations, LLC $13.50 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052922123
Principal investigator 1 MDD US Operations, LLC $2.70 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052922129
Principal investigator 1 MDD US Operations, LLC $5.40 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052922137
Principal investigator 1 MDD US Operations, LLC $6.08 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052922143
Principal investigator 1 MDD US Operations, LLC $20.25 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052922149
Principal investigator 1 MDD US Operations, LLC $16.88 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052922155
Principal investigator 1 MDD US Operations, LLC $17.28 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052922161
Principal investigator 1 MDD US Operations, LLC $5.40 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052922171
Principal investigator 1 MDD US Operations, LLC $17.28 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052922177
Principal investigator 1 MDD US Operations, LLC $5.40 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052922185
Principal investigator 1 MDD US Operations, LLC $5.40 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052922191
Principal investigator 1 MDD US Operations, LLC $5.40 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052922197
Principal investigator 1 MDD US Operations, LLC $5.40 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052922203
Principal investigator 1 MDD US Operations, LLC $2.70 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052922209
Principal investigator 1 MDD US Operations, LLC $20.25 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052922215
Principal investigator 1 MDD US Operations, LLC $2.70 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052922221
Principal investigator 1 MDD US Operations, LLC $5.40 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052922227
Principal investigator 1 MDD US Operations, LLC $5.40 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052922239
Principal investigator 1 MDD US Operations, LLC $5.40 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052922245
Principal investigator 1 MDD US Operations, LLC $3.38 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052922249
Principal investigator 1 MDD US Operations, LLC $23.62 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052922255
Principal investigator 1 MDD US Operations, LLC $10.12 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052922261
Principal investigator 1 MDD US Operations, LLC $6.75 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052922267
Principal investigator 1 MDD US Operations, LLC $6.08 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052922273
Principal investigator 1 MDD US Operations, LLC $5.40 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052922279
Principal investigator 1 MDD US Operations, LLC $2.02 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052922285
Principal investigator 1 MDD US Operations, LLC $6.75 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE AND REHABILITATION
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT LOWER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052923197
Principal investigator 1 MDD US Operations, LLC $40.50 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE AND REHABILITATION
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT LOWER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052923203
Principal investigator 1 MDD US Operations, LLC $10.12 08/15/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE AND REHABILITATION
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT LOWER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052923211
Principal investigator 1 MDD US Operations, LLC $650.00 06/27/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916499
Principal investigator 1 MDD US Operations, LLC $2,000.00 06/27/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916537
Principal investigator 1 MDD US Operations, LLC $1,200.00 06/27/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916561
Principal investigator 1 MDD US Operations, LLC $18.23 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052880925
Principal investigator 1 MDD US Operations, LLC $24.30 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052880935
Principal investigator 1 MDD US Operations, LLC $48.60 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052880947
Principal investigator 1 MDD US Operations, LLC $91.13 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052880957
Principal investigator 1 MDD US Operations, LLC $182.25 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052880967
Principal investigator 1 MDD US Operations, LLC $30.37 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052880977
Principal investigator 1 MDD US Operations, LLC $24.30 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052880989
Principal investigator 1 MDD US Operations, LLC $182.25 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052880999
Principal investigator 1 MDD US Operations, LLC $48.60 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881011
Principal investigator 1 MDD US Operations, LLC $48.60 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881021
Principal investigator 1 MDD US Operations, LLC $18.23 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881033
Principal investigator 1 MDD US Operations, LLC $18.23 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881043
Principal investigator 1 MDD US Operations, LLC $60.75 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881053
Principal investigator 1 MDD US Operations, LLC $607.50 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881063
Principal investigator 1 MDD US Operations, LLC $155.52 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881073
Principal investigator 1 MDD US Operations, LLC $364.50 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881083
Principal investigator 1 MDD US Operations, LLC $24.30 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881093
Principal investigator 1 MDD US Operations, LLC $182.25 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881103
Principal investigator 1 MDD US Operations, LLC $91.13 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881115
Principal investigator 1 MDD US Operations, LLC $30.37 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881127
Principal investigator 1 MDD US Operations, LLC $54.67 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881137
Principal investigator 1 MDD US Operations, LLC $212.63 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881147
Principal investigator 1 MDD US Operations, LLC $182.25 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881157
Principal investigator 1 MDD US Operations, LLC $48.60 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881167
Principal investigator 1 MDD US Operations, LLC $24.30 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881177
Principal investigator 1 MDD US Operations, LLC $18.23 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881187
Principal investigator 1 MDD US Operations, LLC $48.60 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881199
Principal investigator 1 MDD US Operations, LLC $48.60 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881209
Principal investigator 1 MDD US Operations, LLC $30.37 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881219
Principal investigator 1 MDD US Operations, LLC $91.13 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881231
Principal investigator 1 MDD US Operations, LLC $48.60 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881243
Principal investigator 1 MDD US Operations, LLC $24.30 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881257
Principal investigator 1 MDD US Operations, LLC $48.60 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881269
Principal investigator 1 MDD US Operations, LLC $54.67 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881281
Principal investigator 1 MDD US Operations, LLC $91.13 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881291
Principal investigator 1 MDD US Operations, LLC $48.60 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881301
Principal investigator 1 MDD US Operations, LLC $24.30 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881313
Principal investigator 1 MDD US Operations, LLC $151.87 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881325
Principal investigator 1 MDD US Operations, LLC $607.50 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881337
Principal investigator 1 MDD US Operations, LLC $54.67 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881347
Principal investigator 1 MDD US Operations, LLC $48.60 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881357
Principal investigator 1 MDD US Operations, LLC $121.50 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881367
Principal investigator 1 MDD US Operations, LLC $24.30 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881377
Principal investigator 1 MDD US Operations, LLC $48.60 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881389
Principal investigator 1 MDD US Operations, LLC $212.63 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881399
Principal investigator 1 MDD US Operations, LLC $48.60 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881411
Principal investigator 1 MDD US Operations, LLC $48.60 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881425
Principal investigator 1 MDD US Operations, LLC $182.25 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881437
Principal investigator 1 MDD US Operations, LLC $24.30 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881449
Principal investigator 1 MDD US Operations, LLC $48.60 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881459
Principal investigator 1 MDD US Operations, LLC $60.75 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881471
Principal investigator 1 MDD US Operations, LLC $364.50 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881479
Principal investigator 1 MDD US Operations, LLC $30.37 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881491
Principal investigator 1 MDD US Operations, LLC $48.60 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881501
Principal investigator 1 MDD US Operations, LLC $48.60 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881513
Principal investigator 1 MDD US Operations, LLC $48.60 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881523
Principal investigator 1 MDD US Operations, LLC $48.60 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881535
Principal investigator 1 MDD US Operations, LLC $48.60 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881545
Principal investigator 1 MDD US Operations, LLC $212.63 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881557
Principal investigator 1 MDD US Operations, LLC $48.60 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881567
Principal investigator 1 MDD US Operations, LLC $182.25 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881577
Principal investigator 1 MDD US Operations, LLC $182.25 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881586
Principal investigator 1 MDD US Operations, LLC $182.25 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881599
Principal investigator 1 MDD US Operations, LLC $364.50 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881609
Principal investigator 1 MDD US Operations, LLC $24.30 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881619
Principal investigator 1 MDD US Operations, LLC $121.50 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881629
Principal investigator 1 MDD US Operations, LLC $24.30 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881639
Principal investigator 1 MDD US Operations, LLC $48.60 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881649
Principal investigator 1 MDD US Operations, LLC $54.67 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881659
Principal investigator 1 MDD US Operations, LLC $182.25 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881669
Principal investigator 1 MDD US Operations, LLC $151.87 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881681
Principal investigator 1 MDD US Operations, LLC $155.52 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881691
Principal investigator 1 MDD US Operations, LLC $48.60 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881701
Principal investigator 1 MDD US Operations, LLC $155.52 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881711
Principal investigator 1 MDD US Operations, LLC $48.60 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881721
Principal investigator 1 MDD US Operations, LLC $48.60 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881731
Principal investigator 1 MDD US Operations, LLC $48.60 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881741
Principal investigator 1 MDD US Operations, LLC $48.60 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881755
Principal investigator 1 MDD US Operations, LLC $24.30 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881763
Principal investigator 1 MDD US Operations, LLC $182.25 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881777
Principal investigator 1 MDD US Operations, LLC $24.30 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881789
Principal investigator 1 MDD US Operations, LLC $48.60 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881801
Principal investigator 1 MDD US Operations, LLC $48.60 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881811
Principal investigator 1 MDD US Operations, LLC $48.60 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881821
Principal investigator 1 MDD US Operations, LLC $30.37 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881831
Principal investigator 1 MDD US Operations, LLC $212.63 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881843
Principal investigator 1 MDD US Operations, LLC $91.13 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881855
Principal investigator 1 MDD US Operations, LLC $60.75 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881865
Principal investigator 1 MDD US Operations, LLC $54.67 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881875
Principal investigator 1 MDD US Operations, LLC $48.60 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881887
Principal investigator 1 MDD US Operations, LLC $18.23 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE & REHAB
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881897
Principal investigator 1 MDD US Operations, LLC $60.75 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE AND REHABILITATION
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT LOWER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881907
Principal investigator 1 MDD US Operations, LLC $364.50 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE AND REHABILITATION
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT LOWER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881917
Principal investigator 1 MDD US Operations, LLC $1,200.00 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE AND REHABILITATION
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT LOWER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881927
Principal investigator 1 MDD US Operations, LLC $2,000.00 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE AND REHABILITATION
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT LOWER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881939
Principal investigator 1 MDD US Operations, LLC $650.00 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE AND REHABILITATION
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT LOWER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881949
Principal investigator 1 MDD US Operations, LLC $91.13 05/24/2023 Non-covered Recipient Entity
IDAHO PHYSICAL MEDICINE AND REHABILITATION
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT LOWER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052881959